Altimmune Reports Q4 Financial Results: GAAP EPS at -$0.54

Wednesday, 27 March 2024, 11:02

Altimmune released its Q4 earnings report, revealing a GAAP EPS of -$0.54, which fell $0.16 below expectations. The company recorded revenues of $37K. Altimmune's financial performance signals challenges in achieving profitability and meeting market projections.

LivaRava Finance Meta Image — Altimmune Reports Q4 Financial Results: GAAP EPS at -$0.54

Altimmune Financial Report Summary:

Altimmune press release (ALT): Q4 GAAP EPS of -$0.54 misses by $0.16. Revenues of $37K.

This article was prepared using information from open sources in accordance with the principles of Ethical Policy. The editorial team is not responsible for absolute accuracy, as it relies on data from the sources referenced.

Altimmune Financial Report Summary:

Related posts